Ankur Drugs and Pharma board will approve financial results

08 Aug 2012 Evaluate
Ankur Drugs and Pharma has informed that a meeting of the board of directors of the company will be held on August 14, 2012, to approve the un-audited financial results of the company for the quarter ended June 30, 2012 and to consider the appointment of A. K. Khadke, representative of Central Bank of India as nominee director on the board of directors of the company.

The above information is a part of company's filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1713.15
Dr. Reddys Lab 1268.00
Cipla 1489.20
Zydus Lifesciences 901.60
Lupin 2073.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×